Finance

Lists
Q2 2026 earnings • released • EPS beat +18.39% • Revenue beat +139.52%
See results
PRTA:NASDAQ
Prothena Corporation PLC
$8.78
+0.17%
(+0.015) 1D
Aug 10, 2:22:58 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRTA...
Open
$8.76
High
$8.81
Low
$8.53
Mkt. cap
450.48M
Avg. vol.
571.51K
Volume
218.48K
52-wk high
$11.80
52-wk low
$7.40
EPS
-$0.83
Beta
-0.29
Shares outstanding
51.34M
No. of employees
67
Open
$8.76
High
$8.81
Low
$8.53
Mkt. cap
450.48M
Avg. vol.
571.51K
Volume
218.48K
52-wk high
$11.80
52-wk low
$7.40
EPS
-$0.83
Beta
-0.29
Shares outstanding
51.34M
No. of employees
67
News stories
From sources across the web
About Prothena Corporation PLC
CEO-
Employees67
Founded2012
Headquarters-
SectorBiotechnology
Websiteprothena.com
Analyst ratings
Based on 3 analysts giving stock ratings to PRTA in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for PRTA in the last 3 months.
Highest
Current $8.78
$36.00 (+310.26%)
Average
$26.33 (+200.06%)
Lowest
$13.00 (+48.15%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$36.00
+310.3%
08/07/2026
Brian Abrahams
RBC Capital
Hold
Maintained
$13.00
+48.1%
08/06/2026
Andrew Fein
H.C. Wainwright
Buy
Reiterated
$30.00
+241.9%
08/07/2026
Jason Butler
Citizens JMP
Buy
Maintained
$20.00
+127.9%
05/08/2026
Tazeen Ahmad
Bank of America Securities
Sell
Reiterated
$8.00
-8.8%
05/08/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.31 / -$0.38
+18.39%beat
Revenue / Est. (USD)
1.01M / 421.67K
+139.52%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.42M
21.00K
51.08M
1.01M
Cost of goods sold
28.94M
14.59M
12.63M
-
Cost of revenue
28.94M
14.59M
12.63M
8.80M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.24M
12.65M
12.67M
10.90M
Operating expense
13.24M
12.65M
12.67M
10.90M
Total operating expenses
42.18M
27.23M
25.29M
19.70M
Operating income
-39.76M
-27.21M
25.79M
-18.69M
Other non operating income
-
-
-
-
EBT including unusual items
-36.91M
-21.58M
32.72M
-18.58M
EBT excluding unusual items
-36.43M
-24.59M
28.48M
-16.17M
Income tax expense
-371.00K
10.00K
1.00K
2.00K
Effective tax rate
1.00%
-0.05%
-
-0.01%
Other operating expenses
-
-
-
-
Net income
-36.54M
-21.59M
32.72M
-18.58M
Net profit margin
-1,513.08%
-102,804.76%
64.05%
-1,839.90%
Earnings per share
-0.67
-0.46
0.68
-0.31
Interest and investment income
3.35M
2.65M
2.42M
2.55M
Interest expense
-
-
-
-
Net interest expenses
3.35M
2.65M
2.42M
2.55M
Depreciation and amortization charges
-
-
-
-
EBITDA
-39.53M
-26.99M
25.98M
-18.49M
Gain or loss from assets sale
1.00K
101.00K
-
5.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps